Defining a T-cell epitope within HSP 65 in recurrent aphthous stomatitis

被引:30
作者
Hasan, A [1 ]
Shinnick, T
Mizushima, Y
Van der Zee, R
Lehner, T
机构
[1] KCL Univ, GKT Dent Inst, Guys Hosp,GKT Med Sch, Dept Periodontol & Prevent Dent, London SE1 9RT, England
[2] KCL Univ, Dept Immunobiol, Guys Hosp,GKT Med Sch, London SE1 9RT, England
[3] CDC, Atlanta, GA 30333 USA
[4] St Marianna Univ, Kawasaki, Kanagawa, Japan
[5] Natl Inst Publ Hlth & Environm Protect, NL-3720 BA Bilthoven, Netherlands
关键词
peptides; oral ulcers; heat shock protein;
D O I
10.1046/j.1365-2249.2002.01757.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The 65 kD heat shock protein (HSP) has been implicated in the aetiology of recurrent aphthous stomatitis (RAS). We have previously demonstrated that peptide 91-105 derived from the sequence of mycobacterial 65 kD HSP stimulates specifically lymphocytes from patients with RAS. In this investigation, we show that both CD4(+) and CD8(+) T cells were significantly stimulated with mycobacterial peptide 91-105. In contrast, the human homologous peptide 116-130 stimulated only CD4(+) T cells. Inhibition studies showed that CD4(+) T cells were class II restricted, whereas CD8(+) T cells were class I restricted. We then used truncated or substituted peptides, and demonstrated that residues 95-105 appear to be important, and residue 104(Arg) critical, in stimulating the T cells. Thus, peptide 95105 may constitute a T-cell proliferative epitope in RAS. We postulate that the high load of microorganisms that colonize the oral mucosa may initiate an immune response by the microbial HSP 65-derived peptide 95-105, stimulating the numerous Langerhans cells in the oral mucosa to activate a cross-reacting immune response to the homologous peptide 116-130 within the epithelial HSP 60 initiating the immunopathological changes that lead to RAS.
引用
收藏
页码:318 / 325
页数:8
相关论文
共 32 条
[1]   REGIONAL VARIATION IN LANGERHANS CELL DISTRIBUTION AND DENSITY IN NORMAL HUMAN ORAL-MUCOSA DETERMINED USING MONOCLONAL-ANTIBODIES AGAINST CD1, HLADR, HLADQ AND HLADP [J].
CRUCHLEY, AT ;
WILLIAMS, DM ;
FARTHING, PM ;
LESCH, CA ;
SQUIER, CA .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1989, 18 (09) :510-516
[2]  
DOLBY AE, 1969, IMMUNOLOGY, V17, P709
[3]  
DONATSKY O, 1975, SCAND J DENT RES, V83, P111
[4]  
DONATSKY O, 1978, SCAND J DENT RES, V86, P25
[5]  
DONATSKY O, 1974, ARCH DERMATOL, V109, P361
[6]   DIFFERENTIAL PRODUCTION OF INTERFERON-GAMMA AND INTERLEUKIN-4 IN RESPONSE TO TH1-STIMULATING AND TH2-STIMULATING PATHOGENS BY GAMMA-DELTA T-CELLS IN-VIVO [J].
FERRICK, DA ;
SCHRENZEL, MD ;
MULVANIA, T ;
HSIEH, B ;
FERLIN, WG ;
LEPPER, H .
NATURE, 1995, 373 (6511) :255-257
[7]   GAMMA-DELTA-T-CELLS EXPRESSING CD8 OR CD4LOW APPEAR EARLY IN MURINE FETAL THYMUS DEVELOPMENT [J].
FISHER, AG ;
CEREDIG, R .
INTERNATIONAL IMMUNOLOGY, 1991, 3 (12) :1323-1328
[8]  
FORTUNE F, 1990, CLIN EXP IMMUNOL, V82, P326
[9]   RECURRENT APHTHOUS STOMATITIS - CLINICAL THERAPEUTIC HISTOPATHOLOGIC AND HYPERSENSITIVITY ASPECTS [J].
GRAYKOWS.EA ;
BARILE, MF ;
LEE, WB ;
STANLEY, HR .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 196 (07) :637-&
[10]   HUMAN-LYMPHOCYTES BEARING T-CELL RECEPTOR GAMMA-DELTA ARE PHENOTYPICALLY DIVERSE AND EVENLY DISTRIBUTED THROUGHOUT THE LYMPHOID SYSTEM [J].
GROH, V ;
PORCELLI, S ;
FABBI, M ;
LANIER, LL ;
PICKER, LJ ;
ANDERSON, T ;
WARNKE, RA ;
BHAN, AK ;
STROMINGER, JL ;
BRENNER, MB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (04) :1277-1294